Literature DB >> 6236918

Cellular DNA content of T helper, T suppressor and B lymphocytes in SLE.

P Surányi, L Mátyus, I Sonkoly, G Szegedi.   

Abstract

The ratio of in vivo activated T helper, T suppressor and B cells in the blood of patients with SLE has been studied through simultaneous subset specific immunofluorescence labelling and the analysis of cellular DNA content with the help of flow fluorimetry. In the active stage of the disease an increase was observed in the proportion of proliferating cells either among the T helper cells or the B cells. Occasionally, however, the rate of proliferation in both subsets grew at the same time. Cases with a high number of activated B cells have proved to be more serious. The percentage of the T suppressor cells in the S-G2-M phase of the cell cycle increased moderately in both the active and the inactive stages of the disease. Our results are also discussed in relation to the pathogenetic mechanism of SLE.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236918      PMCID: PMC1576966     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus.

Authors:  N I Abdou; A Sagawa; E Pascual; J Hebert; S Sadeghee
Journal:  Clin Immunol Immunopathol       Date:  1976-09

2.  Lack of suppressor cell activity in systemic lupus erythematosus.

Authors:  B Newman; S Blank; R Lomnitzer; P Disler; A R Rabson
Journal:  Clin Immunol Immunopathol       Date:  1979-06

3.  Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease.

Authors:  S Izui; P J McConahey; F J Dixon
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

4.  Antibody penetration into living cells. IV. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated T gamma cells.

Authors:  D Alarcón-Segovia; L Llorente
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

5.  Suppressor T cells in systemic lupus erythematosus: lack of defective in vitro suppressor cell generation in patients with active disease.

Authors:  G C Tsokos; J E Balow
Journal:  J Clin Lab Immunol       Date:  1982-06

6.  Cell cycle analysis of lymphocyte activation in normal and autoimmune strains of mice.

Authors:  E S Raveche; A D Steinberg; A L DeFranco; J H Tjio
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

7.  A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE.

Authors:  E Gleichmann; E H Van Elven; J P Van der Veen
Journal:  Eur J Immunol       Date:  1982-02       Impact factor: 5.532

8.  Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.

Authors:  W W Ginsburg; F D Finkelman; P E Lipsky
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

9.  Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens.

Authors:  R L Evans; T J Faldetta; R E Humphreys; D M Pratt; E J Yunis; S F Schlossman
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice.

Authors:  A N Theofilopoulos; R S Balderas; D L Shawler; S Lee; F J Dixon
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

View more
  2 in total

1.  B lymphocyte activation by insoluble anti-mu antibodies in patients with systemic lupus erythematosus.

Authors:  H Becker; U Schauer; K Helmke
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

2.  Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities.

Authors:  Sudhir Kumar Chauhan; Vikas Vikram Singh; Richa Rai; Madhukar Rai; Geeta Rai
Journal:  J Clin Immunol       Date:  2014-05       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.